These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16185606)

  • 1. Durable clinical benefit with exemestane in leptomeningeal metastasis of breast cancer.
    Navarro Martín LM; Ocaña Fernández A; Rodríguez Sánchez CA; Ruiz Martín I; Cruz Hernández JJ
    Clin Transl Oncol; 2005 Sep; 7(8):358-60. PubMed ID: 16185606
    [No Abstract]   [Full Text] [Related]  

  • 2. Durable Response of Leptomeningeal Metastasis of Breast Cancer to Salvage Intrathecal Etoposide After Methotrexate: A Case Report and Literature Review.
    Park MJ
    Am J Case Rep; 2015 Aug; 16():524-7. PubMed ID: 26258900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.
    Rogers LR; Remer SE; Tejwani S
    Neuro Oncol; 2004 Jan; 6(1):63-4. PubMed ID: 14769142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erlotinib for Progressive Brain and Leptomeningeal Metastases From HER2-positive Breast Cancer After Treatment Failure With Trastuzumab and Lapatinib: Experience and Review of Literature.
    Ji G; Zhang C; Guan S; Yao X
    Clin Breast Cancer; 2018 Oct; 18(5):e759-e765. PubMed ID: 30177482
    [No Abstract]   [Full Text] [Related]  

  • 5. Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab.
    Baculi RH; Suki S; Nisbett J; Leeds N; Groves M
    J Clin Oncol; 2001 Jul; 19(13):3297-8. PubMed ID: 11432901
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer.
    Mir O; Ropert S; Alexandre J; Lemare F; Goldwasser F
    Ann Oncol; 2008 Nov; 19(11):1978-80. PubMed ID: 18845838
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of leptomeningeal metastases from breast cancer to hormonal therapy.
    Chamberlain MC
    Neurology; 2001 Feb; 56(3):425-6. PubMed ID: 11171923
    [No Abstract]   [Full Text] [Related]  

  • 8. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
    Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
    Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of leptomeningeal metastases from breast cancer to hormonal therapy.
    Boogerd W; Dorresteijn LD; van Der Sande JJ; de Gast GC; Bruning PF
    Neurology; 2000 Jul; 55(1):117-9. PubMed ID: 10891918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trastuzumab for breast cancer-related carcinomatous meningitis.
    Robins HI; Liu G; Hayes L; Mehta M
    Clin Breast Cancer; 2002 Jan; 2(4):316. PubMed ID: 11899365
    [No Abstract]   [Full Text] [Related]  

  • 11. Leptomeningeal spread of breast cancer: report of case and review of the literature.
    Sondak V; Deckers PJ; Feller JH; Mozden PJ
    Cancer; 1981 Jul; 48(2):395-9. PubMed ID: 7237408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinomatous meningitis secondary to breast cancer. Spectacular response to hormone therapy].
    Andrés E; Goichot B; Kurtz JE; Dufour P; Imler M; Schlienger JL
    Presse Med; 1999 Jan; 28(2):75. PubMed ID: 9989298
    [No Abstract]   [Full Text] [Related]  

  • 13. Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection.
    Ozdogan M; Samur M; Bozcuk HS; Sagtas E; Yildiz M; Artac M; Savas B
    Jpn J Clin Oncol; 2003 May; 33(5):229-31. PubMed ID: 12865466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.
    Glas M; Stuplich M; Tschampa H; Urbach H; Rasch K; Herrlinger U
    J Neurol; 2008 Nov; 255(11):1838-9. PubMed ID: 18661166
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer.
    Ferrario C; Davidson A; Bouganim N; Aloyz R; Panasci LC
    Ann Oncol; 2009 Apr; 20(4):792-5. PubMed ID: 19223574
    [No Abstract]   [Full Text] [Related]  

  • 16. Leptomeningeal metastasis.
    Taillibert S; Chamberlain MC
    Handb Clin Neurol; 2018; 149():169-204. PubMed ID: 29307353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exemestane: a milestone against breast cancer.
    Shetty YC; Chakkarwar PN; Acharya SS; Rajadhyaksha VD
    J Postgrad Med; 2007; 53(2):135-8. PubMed ID: 17495383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exemestane in the treatment of breast carcinoma: recent findings].
    De Laurentiis M; Criscitiello C; Montanino A; Falato C; Plaitano M
    Tumori; 2008; 94(1):suppl 10-21. PubMed ID: 18468352
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of recurrent breast cancer with liver metastasis responding to exemestane].
    Morohashi S; Morohashi H; Saito C; Odagiri H
    Gan To Kagaku Ryoho; 2009 May; 36(5):811-4. PubMed ID: 19461183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine Therapy for Leptomeningeal Metastases from ER-Positive Breast Cancer: Case Report and a Review of the Literature.
    Zoghi B; Elledge R
    Breast J; 2016; 22(2):218-23. PubMed ID: 26748605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.